Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Top Research Reports for Lam Research, BlackRock & Corning

2026-04-28
Lam Research leads top research picks as AI-driven chip demand fuels strong gains, while BlackRock and Corning ride growth in AUM and optical solutions.

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux

2026-04-28
The Saudi Arabia in vitro diagnostics (IVD) market is set for steady growth, driven by the increasing prevalence of chronic and infectious diseases and enhanced healthcare spending. Estimated to rise from US$ 820.36 million in 2025 to US$ 1.17 billion by 2034, the market is supported by technological advancements, governmental investments under Vision 2030, and a strong focus on early disease detection. Adoption of molecular diagnostics and automated systems is anticipated to fuel market demand,

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

2026-04-28
XYL tops Q1 estimates as Measurement & Control demand lifts results, while raising 2026 revenue outlook.

Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031

2026-04-28
Key market opportunities include growing demand for advanced filtration technologies driven by industrialization and stringent environmental regulations. Smart filtration systems with IoT and AI, self-cleaning technologies, and membrane filtration methods like ultrafiltration and reverse osmosis are becoming crucial for efficiency and sustainability.Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Bulk Filtration Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.Th

CD&R Announces Jim Lico, Former Fortive CEO, as Operating Advisor

2026-04-28
NEW YORK, April 28, 2026--CD&R (or the "Firm") today announced that Jim Lico, former President and Chief Executive Officer of Fortive Corporation (NYSE: FTV), a diversified industrial growth company, has been engaged as an Operating Advisor to CD&R funds. Jim will work with the Firm’s industrials team to help source new investments and advise the funds’ industrials businesses.

3 Profitable Stocks We’re Skeptical Of

2026-04-27
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Danaher Corporation (DHR) Reports Q1 Adjusted EPS Beat

2026-04-25
Danaher Corporation (NYSE:DHR) is one of the 10 Best Slow Growth Stocks to Buy According to Analysts. On April 21, 2026, Danaher Corporation (NYSE:DHR) reported Q1 adjusted EPS of $2.06, above the $1.94 consensus, with revenue of $6B in line with expectations. Rainer Blair said the company “executed well in the first quarter,” citing nearly […]

This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?

2026-04-24
This blue chip stock has been in a multiyear slump, but things are looking up.

Is Danaher (DHR) Now At An Appealing Price After Recent Share Price Weakness

2026-04-24
If you are looking at Danaher and wondering whether the current share price reflects fair value, you are not alone. The stock recently closed at US$178.57, with returns of 7.8% decline over the past week, 6.1% decline over the past month, and 22.5% decline year to date, alongside an 8.5% decline over 1 year, 11.5% decline over 3 years, and 19.6% decline over 5 years. These moves have kept valuation firmly in focus for many investors, especially as long term returns have recently been weaker...

Carlisle Q1 Earnings Beat Estimates, Organic Revenues Decline Y/Y

2026-04-24
CSL beats Q1 earnings estimates but misses on revenues as sales decline and key segments face weak demand despite modest margin gains.